‘The Next Tulip Mania?’ – Fidelity, Gurnet, Biogen Put A Lens To Funding, Valuations

In 2020, Panelists Predicted Bust

 
• By Vibha Ravi

Venture capital funding for biotechs remains aplenty even as listed companies’ stock prices drop. Biogen’s Papadopoulos, Fidelity’s Kaul and Gurnet’s and ex-Sanofi Viehbacher deliberate on whether there is a valuation disconnect and if this is the next "tulip mania."

Tulips
Is This Tulip Mania All Over Again? • Source: Shutterstock

"Tulip mania" was the first documented major economic bubble and also one of the most famous market crashes. It happened during the seventeenth century in Holland when speculators sent prices of tulip bulbs and their forward contracts skyrocketing.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip